Resveratrol: Botanical origin, pharmacological activity and applications

Chinese Journal of Natural Medicines

Volumn 11, Issue 1, 2013, Pages 1-15

  Wu, Chun Fu ^a,b   Yang, Jing Yu ^a,b   Wang, Fang ^a,b   Wang, Xiao Xiao ^a,b  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b Engineering Technology   (China)

Author keywords

Applications; Botanical origin; Pharmacological effects; Resveratrol

Indexed keywords

CASPASE 3; CASPASE 9; CLOFARABINE; CYCLIN D1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEMOGLOBIN A1C; NITRIC OXIDE; PROTEIN P21; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RESVERATROL; SCATTER FACTOR RECEPTOR; SIRTUIN 1; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA1;

ALOE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; ASTER TATARICUS; ASTERACEAE; BARLEY; BAUHINIA; BAUHINIA RACEMOSA; BIOLOGICAL ACTIVITY; BREAST CANCER; CANCER INHIBITION; CANCER INVASION; CARDIOVASCULAR DISEASE; CASSIA; CELL PROLIFERATION; CERCIS CHINENSIS; CYTOTOXICITY; DEGENERATIVE DISEASE; DIABETES MELLITUS; DRUG EFFECT; DRUG STRUCTURE; EUCALYPTUS; FABACEAE; FALLOPIA; FESCUE; GINSENG; HEART PROTECTION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LILIACEAE; LILY; LOLIUM; LUNG CANCER; METASTASIS; MORACEAE; MORUS; NEUROBLASTOMA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORNITHOGALUM CAUDATUM; OXIDATIVE STRESS; PAEONIA LACTIFLORA; PINE; PLANT; POA; POLYGONUM; PROTEIN EXPRESSION; RED WINE; RHEUM; SOYBEAN; TETRASTIGMA HYPOGLAUCUM; VERATUM; VITACEAE;

EID: 84872376924     PISSN: 20956975     EISSN: 18755364     Source Type: Journal    
DOI: 10.1016/S1875-5364(13)60001-1     Document Type: Article

References (145)

1. Borriello A, Cucciolla V, Ragione FD, et al. Dietary polyphenols: Focus on resveratrol, a promising agent in the prevention of cardiovascular diseases and control of glucose homeostasis [J]. Nutr Metab Cardiovas 2010, 20(8):618-625.
2. Langcake P, Pryce R A new class of phytoalexins from grapevines [J]. Cellul Mol Life Sci 1977, 33(2):151-152.
3. Silva MV, Loureiro A, Falcao A, et al. Effect of food on the pharmacokinetic profile of trans-resveratrol [J]. Int J Clin Pharmacol Ther 2008, 46(11):564-570.
4. Ndiaye M, Philippe C, Mukhtar H, et al. The grape antioxidant resveratrol for skin disorders: Promise, prospects, and challenges [J]. Arch Biochem Biophys 2011, 508(2):164-170.
5. Brisdelli F, Andrea GD, Bozzi A Resveratrol: A natural polyphenol with multiple chemopreventive properties [J]. Curr Drug Metab 2009, 10(6):530-546.
6. Li Z, Pang L, Fang F, et al. Resveratrol attenuates brain damage in a rat model of focal cerebral ischemia via up-regulation of hippocampal Bcl-2 [J]. Brain Res 2012, 1450:116-124.
7. Chung JH Using PDE inhibitors to harness the benefits of calorie restriction: lessons from resveratrol [J]. Aging 2012, 4(3):144-145.
8. Jeong JK, Moon MH, Bae BC, et al. Autophagy induced by resveratrol prevents human prion protein-mediated neurotoxicity [J]. Neurosci Res 2012, 73(2):99-105.
9. Soleas GJ, Diamandis EP, Goldberg DM The world of resveratrol [J]. Adv Exp Med Biol 2001, 492:159-182.
10. Timmers S, Auwerx O, Schrauwen P The journey of resveratrol from yeast to human [J]. Aging 2012, 4(3):1-13.
11. Xu Q, Si LY Resveratrol role in cardiovascular and metabolic health and potential mechanisms of action [J]. Nutr Res 2012, 32(9):648-658.
12. Lyons M, Yu C, Toma RB, et al. Resveratrol in raw and baked blueberries and bilberries [J]. J Agric Food Chem 2003, 51(20):5867-5870.
13. Aggarwal BB, Bhardwaj A, Aggarwal RS, et al. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies [J]. Anticancer Res 2004, 24(5A):2783-2840.
14. Gentile C, Tesoriere L, Butera D, et al. Antioxidant activity of Sicilian pistachio (Pistacia vera L. var. Bronte) nut extract and its bioactive components [J]. J Agric Food Chem 2007, 55(3):643-648.
15. Ray PS, Maulik G, Cordis GA, et al. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury [J]. Free Radical Bio Med 1999, 27(1-2):160-169.
16. Gurusamy N, Ray D, Lekli I, et al. Red wine antioxidant resveratrol-modified cardiac stem cells regenerate infarcted myocardium [J]. J Cell Mol Med 2010, 14(9):2235-2239.
17. Hattori R, Otani H, Maulik N, et al. Pharmacological preconditioning with resveratrol: role of nitric oxide [J]. Am J Physiol Heart Circ Physiol 2002, 282(6):1988-1995.
18. Juric D, Wojciechowski P, Das DK, et al. Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol [J]. Am J Physiol-Heart C 2007, 292(5):2138-2143.
19. Csiszar A, Labinskyy N, Olson S, et al. Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats [J]. Hypertension 2009, 54(3):668-675.
20. Das S, Fraga CG, Das DK Cardioprotective effect of resveratrol via HO-1 expression involves p38 map kinase and PI-3-kinase signaling, but does not involve NFκB [J]. Free Radic Res 2006, 40(10):1066-1075.
21. Thirunavukkarasu M, Penumathsa SV, Koneru S, et al. Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase [J]. Free Radic Bio Med 2007, 43(5):720-729.
22. Ungvari Z, Bagi Z, Feher A, et al. Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2 [J]. Am J Physiol-Heart C 2010, 299(1):18-24.
23. Ungvari Z, Orosz Z, Rivera A, et al. Resveratrol increases vascular oxidative stress resistance [J]. Am J Physiol-Heart C 2007, 292(5):2417-2424.
24. Chow SE, Hshu YC, Wang JS, et al. Resveratrol attenuates oxLDL-stimulated NADPH oxidase activity and protects endothelial cells from oxidative functional damages [J]. J Appl Physiol 2007, 102(4):1520-1527.
25. Ungvari Z, Labinskyy N, Mukhopadhyay P, et al. Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells [J]. Am J Physiol-Heart C 2009, 297(5):1876-1881.
26. Csiszar A, Labinskyy N, Podlutsky A, et al. Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations [J]. Am J Physiol-Heart C 2008, 294(6):2721-2735.
27. Csiszar A, Smith K, Labinskyy N, et al. Resveratrol attenuates TNF-a-induced activation of coronary arterial endothelial cells: role of NF-κB inhibition [J]. Am J Physiol-Heart C 2006, 291(4):1694-1699.
28. Ferrero ME, Bertelli A, Fulgenzi A, et al. Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium [J]. Am J Clin Nutr 1998, 68(6):1208-1214.
29. Manna SK, Mukhopadhyay A, Aggarwal BB Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κB, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation [J]. J Immunol 2000, 164(12):6509-6519.
30. Moon SO, Kim W, Sung MJ, et al. Resveratrol suppresses tumor necrosis factor-a-induced fractalkine expression in endothelial cells [J]. Mol Pharmacol 2006, 70(1):112-119.
31. Shigematsu S, Ishida S, Hara M, et al. Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants [J]. Free Radical Bio Med 2003, 34(7):810-817.
32. Tsai SH, Lin-Shiau SY, Lin JK Suppression of nitric oxide synthase and the down-regulation of the activation of NFκB in macrophages by resveratrol [J]. Brit J Pharmacol 1999, 126(3):673-680.
33. 2 production promotes endothelial NF-κB activation in aged rat arteries [J]. Am J Physiol-Heart C 2007, 293(1):37-47.
34. Wung B, Hsu M, Wu C, et al. Resveratrol suppresses IL-6-induced ICAM-1 gene expression in endothelial cells: effects on the inhibition of STAT3 phosphorylation [J]. Life Sci 2005, 78(4):389-397.
35. Wallerath T, Deckert G, Ternes T, et al. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase [J]. Circulation 2002, 106(13):1652-1658.
36. Spanier G, Xu H, Xia N, et al. Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4) [J]. J Physiol Pharmacol 2009, 60(Suppl 4):111-116.
37. Balestrieri ML, Rienzo M, Felice F, et al. High glucose downregulates endothelial progenitor cell number via SIRT1 [J]. BBA-Proteins Proteom 2008, 1784(6):936-945.
38. Arunachalam G, Yao H, Sundar IK, et al. SIRT1 regulates oxidant-and cigarette smoke-induced eNOS acetylation in endothelial cells: Role of resveratrol [J]. Biochem Biophys Res Commun 2010, 393(1):66-72.
39. Csiszar A, Labinskyy N, Pinto JT, et al. Resveratrol induces mitochondrial biogenesis in endothelial cells [J]. Am J Physiol-Heart C 2009, 297(1):13-20.
40. Gracia Sancho J, Villarreal G, Zhang Y, et al. Activation of SIRT1 by resveratrol induces KLF2 expression conferring an endothelial vasoprotective phenotype [J]. Cardiovasc Res 2010, 85(3):514-519.
41. Gurusamy N, Lekli I, Mukherjee S, et al. Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway [J]. Cardiovasc Res 2010, 86(1):103-112.
42. Frojdo S, Durand C, Pirola L Metabolic effects of resveratrol in mammals-a link between improved insulin action and aging [J]. Curr Aging Sci 2008, 1(3):145-151.
43. Szkudelska K, Szkudelski T Resveratrol, obesity and diabetes [J]. Eur J Pharmacol 2010, 635(1):1-8.
44. Fan E, Zhang L, Jiang S, et al. Beneficial effects of resveratrol on atherosclerosis [J]. J Med Food 2008, 11(4):610-614.
45. Lekli I, Szabo G, Juhasz B, et al. Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: the role of GLUT-4 and endothelin [J]. Am J Physiol-Heart C 2008, 294(2):H859-H866.
46. Sharma S, Misra CS, Arumugam S, et al. Antidiabetic activity of resveratrol, a known SIRT1 activator in a genetic model for type 2 diabetes [J]. Phytother Res 2011, 25(1):67-73.
47. Palsamy P, Subramanian S Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats [J]. Biomed Pharmacother 2008, 62(9):598-605.
48. Palsamy P, Subramanian S Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats [J]. Chem-Biol Interact 2009, 179(2-3):356-362.
49. Palsamy P, Subramanian S Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic β-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats [J]. J Cell Physiol 2010, 224(2):423-432.
50. Penumathsa SV, Thirunavukkarasu M, Zhan L, et al. Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium [J]. J Cell Mol Med 2008, 12(6a):2350-2361.
51. Silan C The effects of chronic resveratrol treatment on vascular responsiveness of streptozotocin-induced diabetic rats [J]. Bio Pharm Bull 2008, 31(5):897-902.
52. Su HC, Hung LM, Chen JK Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats [J]. Am J Physiol-Endoc M 2006, 290(6):1339-1346.
53. Szkudelski T Resveratrol inhibits insulin secretion from rat pancreatic islets [J]. Eur J Pharmacol 2006, 552(1):176-181.
54. Macarulla MT, Alberdi G, Gomez S, et al. Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypercaloric diet [J]. J Physiol Biochem 2009, 65(4):369-376.
55. Rocha K, Souza G, Ebaid G, et al. Resveratrol toxicity: effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets [J]. Food Chem Toxicol 2009, 47(6):1362-1367.
56. Shang J, Chen L, Xiao F, et al. Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase1 [J]. Acta Pharmacol Sin 2008, 29(6):698-706.
57. Lee JH, Song MY, Song EK, et al. Overexpression of SIRT1 protects pancreatic β-cells against cytokine toxicity by suppressing the nuclear factor-κB signaling pathway [J]. Diabetes 2009, 58(2):344-351.
58. Robertson RP Oxidative stress and impaired insulin secretion in type 2 diabetes [J]. Curr Opin Pharmacol 2006, 6(6):615-619.
59. Hasko G, Pacher P Endothelial Nrf2 activation: a new target for resveratrol[J]?. Am J Physiol-Heart C 2010, 299(1):H10-H12.
60. Arichi H, Kimura Y, Okuda H, et al. Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism [J]. Chem Pharm Bull (Tokyo) 1982, 30(5):1766-1770.
61. Kimura Y, Ohminami H, Okuda H, et al. Effects of stilbene components of roots of Polygonum ssp. on liver injury in peroxidized oil-fed rats [J]. Planta Med 1983, 49(1):51-54.
62. Goldberg DM Does wine work [J]?. Clin Chem 1995, 41(1):14-16.
63. Soleas GJ, Diamandis EP, Goldberg DM Resveratrol: a molecule whose time has come? And gone[J]?. Clin Biochem 1997, 30(2):91-113.
64. Hou X, Xu S, Maitland-Toolan KA, et al. SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase [J]. J Biol Chem 2008, 283(29):20015-20026.
65. Trincheri NF, Nicotra G, Follo C, et al. Resveratrol induces cell death in colorectal cancer cells by a novel pathway involving lysosomal cathepsin D [J]. Carcinogenesis 2007, 28(5):922-931.
66. Ginkel V, Sareen D, Subramanian L, et al. Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria [J]. Clin Cancer Res 2007, 13(17):5162-5169.
67. Rahman MA, Kim NH, Kim SH, et al. Antiproliferative and cytotoxic effects of resveratrol in mitochondria-mediated apoptosis in rat B103 neuroblastoma cells [J]. Korean J Physiol Pha 2012, 16(5):321-326.
68. Lee YJ, Lee YJ, Im JH, et al. Synergistic anti-cancer effects of resveratrol and chemotherapeutic agent clofarabine against human malignant mesothelioma MSTO-211H cells [J]. Food Chem Toxicol 2013, 52C:61-68.
69. Wang H, Zhang H, Tang L, et al. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis [J]. Toxicology 2012, pii: S0300-483X(12)00373-3.
70. Su JL, Yang CY, Zhao M, et al. Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol [J]. J Biol Chem 2007, 282(27):19385-19398.
71. Golkar L, Ding XZ, Ujiki MB, et al. Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1 [J]. J Surg Res 2007, 138(2):163-169.
72. Bhardwaj A, Sethi G, Vadhan-Raj S, et al. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-κB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells [J]. Blood 2007, 109(6):2293-2302.
73. Tang HY, Shih A, Cao HJ, et al. Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells [J]. Mol Cancer Ther 2006, 5(8):2034-2042.
74. Sun C, Hu Y, Liu X, et al. Resveratrol downregulates the constitutional activation of nuclear factor-κB in multiple myeloma cells, leading to suppression of proliferation and invasion, arrest of cell cycle, and induction of apoptosis [J]. Cancer Genet Cytogen 2006, 165(1):9-19.
75. Hwang J, Kwak DW, LIin S, et al. Resveratrol induces apoptosis in chemoresistant cancer cells via modulation of AMPK signaling pathway [J]. Ann NY Acad Sci 2007, 1095(1):441-448.
76. Cecchinato V, Chiaramonte R, Nizzardo M, et al. Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells [J]. Biochem Pharmacol 2007, 74(11):1568-1574.
77. Benitez DA, Pozo-Guisado E, Alvarez-Barrientos A, et al. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines [J]. J Androl 2007, 28(2):282-293.
78. Sang Kil J, Son Y, Cheong YK, et al. An anticancer/cytotoxic activity of resveratrol is not hampered by its ability to induce the expression of the antioxidant/cytoprotective heme oxygenase-1 in RAW264.7 cells [J]. Biomed Pharmacother 2011, 1(2):146-152.
79. Bai Y, Mao Q, Qin J, et al. Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo [J]. Cancer Sci 2010, 101(2):488-493.
80. Ndiaye M, Philippe C, Mukhtar H, et al. The grape antioxidant resveratrol for skin disorders: Promise, prospects, and challenges [J]. Arch Biochem Biophys 2011, 508(2):164-170.
81. Harper CE, Patel BB, Wang J, et al. Resveratrol suppresses prostate cancer progression in transgenic mice [J]. Carcinogenesis 2007, 28(9):1946-1953.
82. Busquets S, Ametller E, Fuster G, et al. Resveratrol, a natural diphenol, reduces metastatic growth in an experimental cancer model [J]. Cancer Lett 2007, 245(1):144-148.
83. 3H] trans-resveratrol in rat tissues following oral administration [J]. Brit J Nutr 2006, 96(01):62-70.
84. Zamin LL, Dillenburg-Pilla P, Argenta Comiran R, et al. Protective effect of resveratrol against oxygen-glucose deprivation in organotypic hippocampal slice cultures: involvement of PI3-K pathway [J]. Neurobiol Dis 2006, 24(1):170-182.
85. Benitez DA, Pozo Guisado E, Alvarez Barrientos A, et al. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines [J]. J Androl 2007, 28(2):282-293.
86. Bi XL, Yang JY, Dong YX, et al. Resveratrol inhibits nitric oxide and TNF-a production by lipopolysaccharide-activated microglia [J]. Int Immunopharmacol 2005, 5(1):185-193.
87. Meng X, Chen G, Yang J, et al. Inhibitory effect of a novel resveratrol derivative on nitric oxide production in lipopolysaccharide-activated microglia [J]. Pharmazie 2008, 63(9):671-675.
88. Meng XL, Yang JY, Chen GL, et al. Effects of resveratrol and its derivatives on lipopolysaccharide-induced microglial activation and their structure-activity relationships [J]. Chem-Biol Interact 2008, 174(1):51-59.
89. Meng XL, Yang JY, Chen GL, et al. RV09, a novel resveratrol analogue, inhibits NO and TNF-a production by LPS-activated microglia [J]. Int Immunopharmacol 2008, 8(8):1074-1082.
90. Gao ZB, Hu GY Trans-resveratrol, a red wine ingredient, inhibits voltage-activated potassium currents in rat hippocampal neurons [J]. Brain Res 2005, 1056(1):68-75.
91. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis [J]. Nature 1993, 362(6415):59-62.
92. Sharma S, Kulkarni SK, Chopra K Effect of resveratrol, a polyphenolic phytoalexin, on thermal hyperalgesia in a mouse model of diabetic neuropathic pain [J]. Fund Clin Pharmacol 2007, 21(1):89-94.
93. Singh N, Pillay V, Choonara YE Advances in the treatment of Parkinson's disease [J]. Prog Neurobiol 2007, 81(1):29-44.
94. Solans A, Zambrano A, Rodríguez M, et al. Cytotoxicity of a mutant huntingtin fragment in yeast involves early alterations in mitochondrial OXPHOS complexes II and III [J]. Hum Mol Genet 2006, 15(20):3063-3081.
95. Riviere C, Richard T, Quentin L, et al. Inhibitory activity of stilbenes on Alzheimer's β-amyloid fibrils in vitro [J]. Bioorg Med Chem 2007, 15(2):1160-1167.
96. Marambaud P, Zhao H, Davies P Resveratrol promotes clearance of Alzheimer's disease amyloid-β peptides [J]. J Biol Chem 2005, 280(45):37377-37382.
97. Han YS, Zheng WH, Bastianetto S, et al. Neuroprotective effects of resveratrol against β-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C [J]. Brit J Pharmacol 2004, 141(6):997-1005.
98. Vingtdeux V, Giliberto L, Zhao H, et al. AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-β peptide metabolism [J]. J Biol Chem 2010, 285(12):9100-9113.
99. Porquet D, Casadesus G, Bayod S, et al. Dietary resveratrol prevents Alzheimer's markers and increases life span in SAMP8 [J]. Age 2012.
100. Jin F, Wu Q, Lu YF, et al. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats [J]. Eur J Pharmacol 2008, 600(1-3):78-82.
101. Blanchet J, Longpre F, Bureau G, et al. Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice [J]. Prog Neuro-Psychoph 2008, 32(5):1243-1250.
102. Kumar P, Padi SSV, Naidu PS, et al. Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms [J]. Behav Pharmacol 2006, 17(5-6):485-492.
103. + channel pathway in the antiallodynic action of resveratrol [J]. Pharmacol Biochem Be 2006, 84(3):535-542.
104. Zhang F, Liu J, Shi JS Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation [J]. Eur J Pharmacol 2010, 636(1):1-7.
105. Hou RCW, Chen YS, Chen CH, et al. Protective effect of 1, 2, 4-benzenetriol on LPS-induced NO production by BV2 microglial cells [J]. J Biomed Sci 2006, 13(1):89-99.
106. Jung WK, Ahn YW, Lee SH, et al. Ecklonia cava ethanolic extracts inhibit lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in BV2 microglia via the MAP kinase and NF-[kappa] B pathways [J]. Food Chem Toxicol 2009, 47(2):410-417.
107. Barnham KJ, Masters CL, Bush AI Neurodegenerative diseases and oxidative stress [J]. Nat Rev Drug Discov 2004, 3(3):205-214.
108. Wang JY, Wen LL, Huang YN, et al. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of gliamediated inflammation [J]. Curr Pharm Design 2006, 12(27):3521-3533.
109. Candelario-Jalil E, de Oliveira AC, Graf S, et al. Resveratrol potently reduces prostaglandin E2 production and free radical formation in lipopolysaccharide-activated primary rat microglia [J]. J Neuroinflamm 2007, 4(25):1-12.
110. Lorenz P, Roychowdhury S, Engelmann M, et al. Oxyresveratrol and resveratrol are potent antioxidants and free radical scavengers: effect on nitrosative and oxidative stress derived from microglial cells [J]. Nitric Oxide 2003, 9(2):64-76.
111. Guo L, Wang LH, Sun B, et al. Direct in vivo evidence of protective effects of grape seed procyanidin fractions and other antioxidants against ethanol-induced oxidative DNA damage in mouse brain cells [J]. J Agric Food Chem 2007, 55(14):5881-5891.
112. Yan Y, Yang JY, Mou YH, et al. Possible metabolic pathways of ethanol responsible for oxidative DNA damage in human peripheral lymphocytes [J]. Alcohol Clin Exp Res 2011, 35(1):1-9.
113. Guo L, Yang JY, Wu CF Oxidative DNA damage induced by ethanol in mouse peripheral leucocytes [J]. Basic Clin Pharmacol Toxicol 2008, 103(3):222-227.
114. Yan Y, Yang JY, Mou YH, et al. Differences in the activities of resveratrol and ascorbic acid in protection of ethanol-induced oxidative DNA damage in human peripheral lymphocytes [J]. Food Chem Toxicol 2012, 50(2):168-174.
115. Gonthier B, Allibe N, Cottet-Rousselle C, et al. Specific Conditions for Resveratrol Neuroprotection against Ethanol-Induced Toxicity [J]. J Toxicol 2012, 2012:973134.
116. Docherty JJ, McEwen HA, Sweet TJ, et al. Resveratrol inhibition of Propionibacterium acnes [J]. J Antimicrob Chemother 2007, 59(6):1182-1184.
117. Morselli E, Maiuri M, Markaki M, et al. Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy [J]. Cell Death Dis 2010, 1(1):e10.
118. Shetty AK Promise of resveratrol for easing status epilepticus and epilepsy [J]. Pharmacol Therapeut 2011, 131(3):269-286.
119. Goldberg D, Yan J, Soleas G Absorption of three wine-related polyphenols in three different matrices by healthy subjects [J]. Clin Biochem 2003, 36(1):79-87.
120. La PC, Voduc N, Zhang G, et al. Steady-state pharmacokinetics and tolerability of trans-resveratrol 2000mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects [J]. Clin Pharmacokinet 2010, 49(7):449-454.
121. Chow H, Garland L, Hsu C, et al. Resveratrol modulates drug and carcinogen-metabolizing enzymes in a healthy volunteer study [J]. Cancer Prev Res 2010, 3(9):1168-1175.
122. Chachay VS, Kirkpatrick CMJ, Hickman IJ, et al. Resveratrol-pills to replace a healthy diet[J]?. Brit J Clin Pharmacol 2010, 72(1):27-38.
123. Gresele P, Cerletti C, Guglielmini G, et al. Effects of resveratrol and other wine polyphenols on vascular function: an update [J]. J Nutr Biochem 2011, 22(3):201-211.
124. Miceli M, Alberti L, Bennardini F, et al. Effect of low doses of ethanol on platelet function in long-life abstainers and moderate wine drinkers [J]. Life Sci 2003, 73(12):1557-1566.
125. Timmers S, Auwerx J, Schrauwen P The journey of resveratrol from yeast to human [J]. Aging 2012, 4(3):1-13.
126. Boocock D, Patel K, Faust G, et al. Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography [J]. J Chromatogr B, Analyt Technol Biomed Life Sci 2007, 848(2):182-187.
127. Almeida L, Vazda SM, Falcao A, et al. Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers [J]. Mol Nutr Food Res 2009, 53(1):7-15.
128. Nunes T, Almeida L, Rocha J, et al. Pharmacokinetics of trans-resveratrol following repeated administration in healthy elderly and young subjects. [J]. J Clin Pharmacol 2009, 49(12):1477-1482.
129. Vitaglione P, Sforza S, Galaverna G, et al. Bioavailability of trans-resveratrol from red wine in humans [J]. Mol Nutr Food Res 2005, 49(5):495-504.
130. Brown V, Patel K, Viskaduraki M, et al. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis [J]. Cancer Res 2010, 70(22):9003-9011.
131. Meng X, Maliakal P, Lu H, et al. Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice [J]. J Agric Food Chem 2004, 52(4):935-942.
132. Patel K, Brown V, Jones D, et al. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients [J]. Cancer Res 2010, 70(19):7392-7399.
133. Ortuño J, Covas MI, Farre M, et al. Matrix effects on the bioavailability of resveratrol in humans. [J]. Food Chem 2010, 120(4):1123-1130.
134. Walle T, Hsieh F, DeLegge M, et al. High absorption but very low bioavailability of oral resveratrol in humans [J]. Drug Metab Dispos 2004, 32(12):1377-1382.
135. Gresele P, Pignatelli P, Guglielmini G, et al. Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. [J]. J Nutr 2008, 138(9):1602-1608.
136. Urpi SM, Jauregui O, Lamuela RR, et al. Uptake of diet resveratrol into the human low-density lipoprotein. Identification and quantification of resveratrol metabolites by liquid chromatography coupled with tandem mass spectrometry [J]. Anal Chem 2005, 77(10):3149-3155.
137. Ghanim H, Sia C, Korzeniewski K, et al. A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. [J]. J Clin Endocrinol Metab 2011, 96(5):1409-1414.
138. Kennedy D, Wightman E, Reay J, et al. Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation [J]. Am J Clin Nutr 2010, 91(6):1590-1597.
139. Wong RH, PR H, JD B Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure [J]. Nutr Metab Cardiovasc Dis 2011, 21(11):851-856.
140. Nguyen A, Martinez M, Stamos M, et al. Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer [J]. Cancer Manag Res 2009, 1:25-37.
141. Patel KR, Scott E, Brown VA, et al. Clinical trials of resveratrol [J]. Ann NY Acad Sci 2011, 1215:161-169.
142. Elliott P, Walpole S, Morelli L, et al. Resveratrol/SRT-501 [J]. Drugs Fut 2009, 34(4):291-295.
143. Brasnyo P, Molnar G, Mohas M, et al. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients [J]. Br J Nutr 2011, 106(3):383-389.
144. Timmers S, Konings E, Bilet L, et al. Calorie Restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. [J]. Cell Metab 2011, 14(5):612-622.
145. Crandall J, Oram V, Trandafirescu G, et al. Pilot study of resveratrol in older adults with impaired glucose tolerance. [J]. J Gerontol A-Biol 2012, 67(12):1307-1312.